EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hao‐Fountain syndrome: 32 novel patients reveal new insights into the clinical spectrum

Moritz Claudius Wimmer iD, Heiko Brennenstuhl iD, Steffen Hirsch, Laura Dötsch, Samy Unser, Pilar Caro iD, Christian Patrick Schaaf

Clinical Genetics · 2024

DOI: 10.1111/cge.14480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, 2024. Verfasst von Moritz Claudius Wimmer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, Heidelberg University, Heidelberg, Germany. Hauptthemen laut MEDLINE: Intellectual Disability, Abnormalities, Multiple, Craniofacial Abnormalities, Neurodevelopmental Disorders. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hao‐Fountain syndrome (HAFOUS, OMIM: #616863) is a neurodevelopmental disorder caused by pathogenic variants in the gene USP7 coding for USP7, a protein involved in several crucial cellular homeostatic mechanisms and the recently described MUST complex. The phenotype of HAFOUS is insufficiently understood, yet there is a great need to better understand the spectrum of disease, genotype–phenotype correlations, and disease trajectories. We now present a larger cohort of 32 additional individuals and provide further clinical information about six previously reported individuals. A questionnaire‐based study was performed to characterize the phenotype of Hao‐Fountain syndrome more clearly, to highlight new traits, and to better distinguish the disease from related neurodevelopmental disorders. In addition to confirming previously described features, we report hyperphagia and increased body weight in a subset of individuals. HAFOUS patients present an increased rate of birth complications, congenital anomalies, and abnormal pain thresholds. Speech impairment emerges as a potential hallmark of Hao‐Fountain syndrome. Cognitive testing reports reveal borderline intellectual functioning on average, although some individuals score in the range of intellectual disability. Finally, we created a syndrome‐specific severity score. This score neither indicates a sex‐ nor age‐specific difference of clinical severity, yet highlights a more severe outcome when amino acid changes colocalize to the catalytic domain of the USP7 protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual DisabilityAbnormalities, MultipleCraniofacial AbnormalitiesNeurodevelopmental DisordersBone Diseases, DevelopmentalDeafnessHumansUbiquitin-Specific Peptidase 7Phenotype

Stichwörter der Autor:innen

Hao‐Fountain syndromeUSP7clinical spectrumgenotype–phenotype associationneurodevelopmental disorderrare disease

Substanzen

Ubiquitin-Specific Peptidase 7USP7 protein, human

Autor:innen und Institutionen

  • Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Moritz Claudius Wimmer, Heiko Brennenstuhl, Pilar Caro

Zitieren

APA

Wimmer, M. C., Brennenstuhl, H., Hirsch, S., Dötsch, L., Unser, S., Caro, P., & Schaaf, C. P. (2024). Hao‐Fountain syndrome: 32 novel patients reveal new insights into the clinical spectrum. Clinical Genetics. https://doi.org/10.1111/cge.14480

Vancouver

Wimmer MC, Brennenstuhl H, Hirsch S, Dötsch L, Unser S, Caro P, et al. Hao‐Fountain syndrome: 32 novel patients reveal new insights into the clinical spectrum. Clinical Genetics. 2024. doi:10.1111/cge.14480

BibTeX
@article{Wimmer2024,
  author = {Wimmer, Moritz Claudius and Brennenstuhl, Heiko and Hirsch, Steffen and Dötsch, Laura and Unser, Samy and Caro, Pilar and Schaaf, Christian Patrick},
  title = {Hao‐Fountain syndrome: 32 novel patients reveal new insights into the clinical spectrum},
  journal = {Clinical Genetics},
  year = {2024},
  doi = {10.1111/cge.14480}
}
Kostenlos starten →